Newsroom Navigation

Contact Info:
Office of Public Affairs
2000 Circle of Hope,
Salt Lake City, UT 84112

public.affairs@hci.utah.edu

801-587-7639

Recent News

The Young Sperm, Poised for Greatness
News, Press Releases

The Young Sperm, Poised for Greatness

In the body, a skin cell will always be skin, and a heart cell will always be heart. But in the first hours of life, cells in the nascent embryo become totipotent: they have the incredible flexibility to mature into skin, heart, gut, or any type of cell.

Read More

The Renegades of Cell Biology: Researchers Discover Why K-Ras Gene Mutations Prove So Deadly in Cancer
News, Press Releases

The Renegades of Cell Biology: Researchers Discover Why K-Ras Gene Mutations Prove So Deadly in Cancer

Cells with a mutation in the gene called K-Ras—found in close to 30% of all cancers, but mostly those with worst prognosis, such as pancreatic cancer, colon cancer, and lung cancer—behave in ways that subvert the normal mechanisms of cell death, according to a cell-culture study by researchers from Huntsman Cancer Institute (HCI) at the University of Utah.

Read More

Cervical Cancer Screening Overused in Some Groups of Women
News, Press Releases

Cervical Cancer Screening Overused in Some Groups of Women

For the past ten years, clinicians throughout the United States have been performing unnecessary Pap tests for cervical cancer screening in certain groups of women, according to a researcher from Huntsman Cancer Institute (HCI) at the University of Utah.

Read More

Children's and Families' Cancers Target of New Research Initiative
News, Press Releases

Children's and Families' Cancers Target of New Research Initiative

At a time when the incidence and prevalence of cancers in all age groups—including children—is increasing, and funding for cancer research is on the decline, officials at Huntsman Cancer Institute at the University of Utah today announced a plan to expand HCI’s research capabilities—a new, 220,000-square-foot addition.

Read More

Children's Cancer Target of $1.73MM Grant
Awards, Press Releases

Children's Cancer Target of $1.73MM Grant

CureSearch for Children's Cancer this week awarded researchers at Huntsman Cancer Institute at the University of Utah a $1.73 million grant to test a novel targeted treatment for Ewing sarcoma that hopefully will disrupt the cancer's growth and spread. If successful, their work could lead to new treatment for the more than 250 children diagnosed with this rare cancer each year.

Read More

Melanoma Linked to Chronic Sun Damage Target of $1.5 MM Grant
Press Releases

Melanoma Linked to Chronic Sun Damage Target of $1.5 MM Grant

The National Cancer Institute (NCI) has awarded Huntsman Cancer Institute investigator Matt VanBrocklin, Ph.D., more than $1.5 million over the next five years to continue studying the role of a gene called c-KIT in the origin and growth of melanoma, a devastating and sometimes deadly skin cancer. VanBrocklin is an assistant professor in the Department of Surgery at the University of Utah.

Read More

Family Members of Children With Cancer May Also Be At Risk
Press Releases

Family Members of Children With Cancer May Also Be At Risk

When a child is diagnosed with cancer, one of the first questions the parents ask is "Will my other children get cancer?" A new study from Huntsman Cancer Institute (HCI) at the University of Utah suggests the answer to that question depends on whether or not a family history of cancer exists. The research results were published online in the International Journal of Cancer and will appear in the November 15 print issue.

Read More

At Fertilization Dad's Genome More Ready Than Mom's; but Mom's Catches Up on Its Own
News, Press Releases

At Fertilization Dad's Genome More Ready Than Mom's; but Mom's Catches Up on Its Own

Researchers from Huntsman Cancer Institute (HCI) at the University of Utah have discovered that while the genes provided by the father arrive at fertilization pre-programmed to the state needed by the embryo, the genes provided by the mother are in a different state and must be reprogrammed to match. The findings have important implications for both developmental biology and cancer biology.

Read More

A Powerful, More Accurate, Genetic Analysis Tool Opens New Gene-Regulation Realms
News, Press Releases

A Powerful, More Accurate, Genetic Analysis Tool Opens New Gene-Regulation Realms

Researchers from Huntsman Cancer Institute (HCI) at the University of Utah have developed a novel and powerful technique to identify the targets for a group of enzymes called RNA cytosine methyltransferases (RMTs) in human RNA. They applied their technique to a particular RMT, NSUN2, which has been implicated in mental retardation and cancers in humans, finding and validating many previously unknown RMT targets—an indication of the technique's power. The research results were published online in the journal Nature Biotechnology on April 21.

Read More

New Medical Director Named at the University of Utah's Huntsman Cancer Institute
News, Press Releases

New Medical Director Named at the University of Utah's Huntsman Cancer Institute

John Sweetenham, M.D., currently a Professor of Medicine at the University of California, San Diego, and Medical Director of the UCSD University of Nevada Cancer Institute, has been appointed Senior Director of Clinical Affairs and Executive Medical Director at Huntsman Cancer Institute (HCI), and Professor in the Department of Medicine, Division of Hematologic Oncology at the University of Utah after a national search. He will assume his post April 1.

Read More

Geography Matters:  When Where You Live May Determine If You Live
News, Press Releases

Geography Matters: When Where You Live May Determine If You Live

People who reside in rural areas of Utah are less likely to follow colorectal cancer (CRC) screening recommendations than their urban counterparts, according to researchers from Huntsman Cancer Institute (HCI) at the University of Utah. This geographic disparity is evident across all risk groups, including those who have a family history of the disease.

Read More

News, Press Releases

Clinical Trial Delivers Good Results in Leukemia Patients

HCI researchers were part of a team that found a potent oral drug, ponatinib, effective in patients who have developed resistance to standard treatments for chronic myeloid leukemia (CML) and Philadelphia chromosome positive acute lymphoblastic lymphoma (Ph+ ALL).

Read More

Possible New Treatment for a Childhood Cancer
News, Press Releases

Possible New Treatment for a Childhood Cancer

Discovery of a new drug with high potential to treat Ewing sarcoma, an often deadly cancer of children and young adults, and the previously unknown mechanism behind it, come hand-in-hand in a new study by researchers from Huntsman Cancer Institute (HCI) at the University of Utah. The report appears in today’s online issue of the journal Oncogene.

Read More

New Discovery about DNA Packaging
News, Press Releases

New Discovery about DNA Packaging

A new discovery from researchers at HCI concerning a fundamental understanding about how DNA works will produce a "180-degree change in focus" for researchers who study how gene packaging regulates gene activity, including genes that cause cancer and other diseases.

Read More


Our media relations representatives are here to help reporters Monday-Friday, 7:30 am-5 pm.

Debby Rogers
Public Affairs Manager
Phone: 801-587-7639
debby.rogers@hci.utah.edu

Amie Parker
Public Relations Associate
Phone: 801-213-5755
amie.parker@hci.utah.edu

Jill Woods
Administrative Assistant
Phone: 801-585-5321
Fax: 801-585-0900
jill.woods@hci.utah.edu

After-hours calls: Reporters calling before or after business hours on an urgent matter can page the University of Utah Health on-call media relations representative at 801-581-7387 and press 1.